MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

PPersonalized chemosensitivity assays for mesothelioma- is it worth the effort?

Clinical cancer research 2018 January 19 [Epub ahead of print] [Link]

John T, Chia PL

Abstract

Cell-lines formed from an individual’s tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of current therapeutic paradigms, such assays could be used to treat patients with the most effective agents specific to their “chemical profile”

Both comments and trackbacks are currently closed.